2020
DOI: 10.1016/j.ultrasmedbio.2019.11.007
|View full text |Cite
|
Sign up to set email alerts
|

Seeing the Invisible—Ultrasound Molecular Imaging

Abstract: Ultrasound molecular imaging has been developed in the past two decades with the goal of non-invasively imaging disease phenotypes on a cellular level not depicted on anatomic imaging. Such techniques already play a role in pre-clinical research for the assessment of disease mechanisms and drug effects, and are thought to in the future contribute to earlier diagnosis of disease, assessment of therapeutic effects and patient-tailored therapy in the clinical field. In this review, we first describe the chemical … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
28
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 38 publications
(28 citation statements)
references
References 151 publications
(213 reference statements)
0
28
0
Order By: Relevance
“…Ultrasound imaging can now use microbubbles and other contrast agents coated with specific targeting ligand molecules that bind selectively to the site of interest 14 . Thrombus‐targeted imaging technologies use ligands that are specific either for fibrin, 15 activated platelets expressing the integrin αIIbβ3, 16 or prothrombotic components such as factor XIIIa, 17 tissue factor, von Willebrand factor, or exposed collagen 14 . Noninvasive molecular imaging techniques targeting thrombus components have been used both in disease‐state animal models and in clinical applications.…”
Section: Visualizing Thrombi In Vivo and Ex Vivomentioning
confidence: 99%
See 2 more Smart Citations
“…Ultrasound imaging can now use microbubbles and other contrast agents coated with specific targeting ligand molecules that bind selectively to the site of interest 14 . Thrombus‐targeted imaging technologies use ligands that are specific either for fibrin, 15 activated platelets expressing the integrin αIIbβ3, 16 or prothrombotic components such as factor XIIIa, 17 tissue factor, von Willebrand factor, or exposed collagen 14 . Noninvasive molecular imaging techniques targeting thrombus components have been used both in disease‐state animal models and in clinical applications.…”
Section: Visualizing Thrombi In Vivo and Ex Vivomentioning
confidence: 99%
“…14 Thrombus-targeted imaging technologies use ligands that are specific either for fibrin, 15 activated platelets expressing the integrin αIIbβ3, 16 or prothrombotic components such as factor XIIIa, 17 tissue factor, von Willebrand factor, or exposed collagen. 14 To visualize flowing blood, blood cells, and thrombi, intravital molecular-based fluorescence imaging has been widely used in animal models of thrombosis. 19,20 Various blood components are labeled with different dyes and fluorescent antibodies followed by intravital epifluorescence or fluorescent confocal microscopy that allows time-lapse imaging to track formation and maturation of a thrombus.…”
Section: Visualizing Thrombi In Vivo and Ex Vivomentioning
confidence: 99%
See 1 more Smart Citation
“… 12 As contrast-imaging agents, in addition to anatomic imaging, NBs are used in imaging phenotypes at a cellular level, contributing to disease detection and assessment. 13 As delivery systems, NBs, by delivering chemical agents, genes and protein materials in a targeted manner, 14 , 15 enhance the treatment effect and prevent side effects. Their nanometer size facilitates their movement through the capillary endothelial cell gap to the tumor, thus causing enhanced permeability and retention (EPR) effect.…”
Section: Introductionmentioning
confidence: 99%
“…Microbubbles are small gas bubbles (diameter 1-10 µm) that are clinically used as ultrasound contrast agents for non-invasive diagnostic imaging of blood perfusion [1]. Targeted microbubbles are employed for molecular imaging of inflammation, tumors, and cardiovascular disease [2]. Other types of microbubbles are being developed specifically for drug delivery [3].…”
Section: Introductionmentioning
confidence: 99%